| 摘要 |
Certain novel substituted imidazole 4-carboxamides of formula (I): (see formula I) and pharmaceutically acceptable salts thereof, are ligands of the human cholecystokinin receptor and, in particular, are selective ligands of the human cholecystokinin-1 receptor (CCK-1R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of CCK-1R, such as obesity, and diabetes.
|
